Actively Recruiting

Age: 18Years +
All Genders
NCT06257407

Perioperative Hemostasis Management in Liver Transplantation

Led by Société Française d'Anesthésie et de Réanimation · Updated on 2026-04-02

1200

Participants Needed

16

Research Sites

115 weeks

Total Duration

On this page

Sponsors

S

Société Française d'Anesthésie et de Réanimation

Lead Sponsor

L

Laboratoire français de Fractionnement et de Biotechnologies

Collaborating Sponsor

AI-Summary

What this Trial Is About

Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neohepatic. However, intraoperative bleeding and transfusion requirements remain difficult to predict. Current predictive models are based in particular on preoperative characteristics and do not take into account the course and different phases of the operation. The need for transfusions has largely decreased over the last 20 years, and currently around 20-25% of patients are transfused (transfusion of at least 1 blood product during LT). However, massive transfusion is necessary in 10% of LT. The European Society of Anaesthesiology (ESA) has issued recommendations on the management of severe bleeding during surgery. However, these recommendations are not specific to LT. Moreover, transfusion strategies vary widely from one center to another. The implementation of protocols within teams dedicated to LT has led to a reduction in bleeding and transfusion, with or without the use of viscoelastic testing. Intraoperative bleeding and transfusion requirements, as well as postoperative thromboembolic complications, remain difficult to predict. Predictive models of bleeding risk have been developed, but they are based solely on preoperative characteristics and do not take into account the course and various phases of the operation. In addition, new methods such as Bayesian inference or machine learning have been developed, and seem capable of providing different information from that obtained by conventional models. The overall aim of this prospective multicenter observational study is to investigate the risk factors for bleeding and thrombosis in per- and post-operative LT using different predictive methods, and to describe the management of bleeding and post-operative anticoagulation in metropolitan France.

CONDITIONS

Official Title

Perioperative Hemostasis Management in Liver Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 or over
  • Liver transplant patient
Not Eligible

You will not qualify if you...

  • Multi-organ transplantation
  • Protected populations: under guardianship or curatorship
  • Patients not affiliated to a social security scheme

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 16 locations

1

Chru Minjoz

Besançon, France

Actively Recruiting

2

CHU Estaing

Clermont, France

Not Yet Recruiting

3

Hôpital Beaujon

Clichy, France

Not Yet Recruiting

4

CHU Grenoble Alpes

Grenoble, France

Not Yet Recruiting

5

CHU Claude Huriez

Lille, France

Actively Recruiting

6

Hôpital de la Croix-Rousse

Lyon, France

Actively Recruiting

7

CHU La Timone

Marseille, France

Not Yet Recruiting

8

Hôpital St Eloi

Montpellier, France

Not Yet Recruiting

9

Hôpital De L'Archet 2

Nice, France

Not Yet Recruiting

10

CHU Pitié-Salpêtrière

Paris, France

Not Yet Recruiting

11

CHU Haut Levêque

Pessac, France

Not Yet Recruiting

12

CHU Pontchaillou

Rennes, France

Not Yet Recruiting

13

CHU Hautepierre

Strasbourg, France

Not Yet Recruiting

14

CHU Toulouse Rangueil

Toulouse, France

Not Yet Recruiting

15

CHU Tours

Tours, France

Not Yet Recruiting

16

Hôpital Paul Brousse

Villejuif, France

Actively Recruiting

Loading map...

Research Team

E

Emmanuel WEISS, MD

CONTACT

S

Stéphanie ROULLET, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Perioperative Hemostasis Management in Liver Transplantation | DecenTrialz